AMRI named Susan Collins director of business development for North American Discovery Services, reporting to Christopher Conway, vice president of business development. Collins is responsible for leading a team promoting AMRI's global drug discovery services.

With 19 years of pharmaceutical industry and leadership experience, Collins will manage business development activities and professionals and spearhead AMRI's efforts to expand discovery opportunities and business within the sector.

Collins has worked in sales and leadership positions at Organon BioSciences, which was later acquired by Schering-Plough and Merck. As region sales director, she was responsible for leading management and representative teams in the promotion of CNS, cardiovascular, anti-infective, anesthesia, pain management and contraceptive products to the medical community across 28 states. Directing teams of up to 125 employees, Collins was responsible for generating sales of more than $174 million with a $7.8 million operating budget.